Lack of cortisol response in patients with posttraumatic stress disorder (PTSD) undergoing a diagnostic interview by Kolassa, Iris-Tatjana et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Psychiatry
Open Access Research article
Lack of cortisol response in patients with posttraumatic stress 
disorder (PTSD) undergoing a diagnostic interview
Iris-Tatjana Kolassa*1, Cindy Eckart1, Martina Ruf1, Frank Neuner1, 
Dominique JF de Quervain2 and Thomas Elbert1
Address: 1Clinical & Neuropsychology, University of Konstanz, Universitätsstr. 10, 78457 Konstanz, Germany and 2Division of Psychiatry 
Research, University of Zürich, Lenggstr. 31, 8032 Zürich, Switzerland
Email: Iris-Tatjana Kolassa* - Iris.Kolassa@uni-konstanz.de; Cindy Eckart - Cindy.Eckart@uni-konstanz.de; Martina Ruf - Martina.Ruf@uni-
konstanz.de; Frank Neuner - Frank.Neuner@uni-konstanz.de; Dominique JF de Quervain - Quervain@bli.unizh.ch; 
Thomas Elbert - Thomas.Elbert@uni-konstanz.de
* Corresponding author    
Abstract
Background: According to DSM-IV, the diagnosis of posttraumatic stress disorder (PTSD) requires the
experience of a traumatic event during which the person's response involved intense fear, helplessness, or
horror. In order to diagnose PTSD, clinicians must interview the person in depth about his/her previous
experiences and determine whether the individual has been traumatized by a specific event or events.
However, asking questions about traumatic experiences can be stressful for the traumatized individual and
it has been cautioned that subsequent "re-traumatization" could occur. This study investigated the cortisol
response in traumatized refugees with PTSD during a detailed and standardized interview about their
personal war and torture experiences.
Methods: Participants were male refugees with severe PTSD who solicited an expert opinion in the
Psychological Research Clinic for Refugees of the University of Konstanz. 17 patients were administered
the Vivo Checklist of War, Detention, and Torture Events, a standardized interview about traumatic
experiences, and 16 subjects were interviewed about absorption behavior. Self-reported measures of
affect and arousal, as well as saliva cortisol were collected at four points. Before and after the experimental
intervention, subjects performed a Delayed Matching-to-Sample (DMS) task for distraction. They also
rated the severity of selected PTSD symptoms, as well as the level of intrusiveness of traumatic memories
at that time.
Results: Cortisol excretion diminished in the course of the interview and showed the same pattern for
both groups. No specific response was detectable after the supposed stressor. Correspondingly, ratings
of subjective well-being, memories of the most traumatic event(s) and PTSD symptoms did not show any
significant difference between groups. Those in the presumed stress condition did not perform worse than
persons in the control condition after the stressor. However, both groups performed poorly in the DMS
task, which is consistent with memory and concentration problems demonstrated in patients with PTSD.
Conclusion: A comprehensive diagnostic interview including questions about traumatic events does not
trigger an HPA-axis based alarm response or changes in psychological measures, even for persons with
severe PTSD, such as survivors of torture. Thus, addressing traumatic experiences within a safe and
empathic environment appears to impose no unacceptable additional load to the patient.
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Background
Severe traumatic experiences such as torture and war fre-
quently produce long-term psychological effects that can
persist over decades, and even into old age [1]. During tor-
ture, the individual is rendered completely helpless and is
often overwhelmed by fear and horror, which is likely to
cause a trauma-related psychological disorder. Torture vic-
tims frequently experience symptoms of PTSD, as deline-
ated by the DSM-IV [2]. These symptoms include:
recurrent memories of the traumatic event in the form of
intrusions and nightmares, avoidance of thoughts and/or
places associated with the traumatic event, enhanced vig-
ilance and hyperarousal, sleep disturbances, and emo-
tional numbing. If these symptoms persist for more than
one month, posttraumatic stress disorder (PTSD) is diag-
nosed. Prevalence rates of PTSD between 45% and over
90% have been reported in survivors of torture [1,3,4].
There is growing evidence that extremely stressful adverse
experiences have a lasting impact on the neurobiology of
the stress response, involving both baseline (tonic) abnor-
malities [5,6] and abnormal responsivity (phasic abnor-
malities) of the hormonal stress system [5,7]. Stress leads
to the excretion of corticotrophin-releasing factor (CRF)
and arginine vasopressin (AVP) into the hypophysial
blood supply, where they are transported to the adenohy-
pophysis. Here they activate pituitary corticoptrophs to
synthesize and release adrenocorticotrophic hormone
(ACTH) into the general blood circulation. CRH is the
most potent ACTH secretagogue. Although the role of AVP
is not yet completely understood, it seems to be involved
in the regulation of stress-induced ACTH release [8].
ACTH circulates in the blood to the zona fasciculata of the
adrenal cortex, where it promotes the conversion of cho-
lesterol esters into free cholesterol and ultimately results
in the release of cortisol as the end product of the steroid
pathway from the adrenal cortex into the circulatory sys-
tem. Cortisol peaks are typically seen 15–30 minutes after
an ACTH pulse in normal human subjects [for a summary
see [9]]. After an acute psychological stressor, peak corti-
sol responses occur 20–40 minutes from the onset of the
stressor in healthy controls, with the length of the stressor
not associated with observed effect sizes (i.e. longer stres-
sors do not lead to greater cortisol responses than shorter
ones [10]).
Several studies have investigated the effect of traumatic
life experiences and PTSD on the pituitary-adrenal cortical
system. However, results have been inconsistent and
sometimes even contradictory [for an overview see e.g.,
[5,7]]. According to the original glucocorticoid cascade
hypothesis  [11], chronic exposure to glucocorticoids
throughout life, secondary to repeated or traumatic stress,
downregulates the central glucocorticoid receptors, espe-
cially at the hippocampal level. This causes impairment of
HPA sensitivity to the negative steroid feedback, leading
to glucocorticoid overproduction in a feedforward loop.
In contrast to this original hypothesis, several studies
reported lower baseline cortisol levels in PTSD in plasma
[12-14], saliva [15-17], and urine [18-21], but some stud-
ies have found significantly higher cortisol excretion [e.g.,
[22]] or no differences between groups [e.g., [23-25]].
In addition to the investigation of baseline alterations in
PTSD patients, several challenge paradigms have been
developed to investigate the stress response in PTSD
patients. These paradigms can be broadly distinguished in
pharmacological and non-pharmacological challenge
tests [for a review see [7]]. Pharmacological challenge tests
target the HPA axis at different levels, e.g. dexamethasone
suppression test, ACTH-, CRH-, and naloxone challenges,
dexamethasone CRH test and metyrapone challenge
designs. In their review, de Kloet et al. [7] conclude that
enhanced cortisol suppression after administration of .5
mg dexamethasone is a relatively well-corroborated find-
ing. Otherwise the results of pharmacological challenge
paradigms are still inconclusive.
In comparison to pharmacological challenge tests rela-
tively few non-pharmacological challenge tests have been
conducted with PTSD patients [26-30]. In these para-
digms, cortisol levels were investigated after cognitive
[29], psychosocial [30], or physical challenges [28], as
well as in response to personalized traumatic scripts [27]
and trauma reminders [26].
Challenge paradigms using non-trauma-related stressors
such as psychosocial or physical stressors found mixed
results: Using a cognitive challenge task, Bremner et al.
[29] found higher mean salivary cortisol levels in anticipa-
tion of, and during the stressor in PTSD patients com-
pared to controls. This effect was more pronounced in
male PTSD patients compared with female PTSD patients.
However, aside from these baseline differences, no evi-
dence for a changed cortisol response to cognitive stres-
sors in PTSD was observed. Instead, the cortisol response
was similar in the PTSD and control group. Using a phys-
ical stressor (cold pressor task), Santa Ana et al. [28] inves-
tigated ACTH/cortisol excretion in individuals with PTSD,
comorbid alcohol dependence and PTSD, and controls. In
this paradigm, subjects immerse one hand in a cold water
bath for up to 1 minute or as long as they can tolerate.
Regardless of the presence or absence of comorbid alcohol
dependence, subjects with childhood trauma and PTSD
(but not adult trauma and PTSD) had lower plasma corti-
sol at baseline and at all post-task measurement points.
No differences in cortisol reagibility were observed. How-
ever, while control persons exhibited an initial ACTH
increase in response to the stressor, traumatized persons
(childhood and adult trauma) showed a blunted ACTHBMC Psychiatry 2007, 7:54 http://www.biomedcentral.com/1471-244X/7/54
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excretion. In contrast, Heim et al. [30] reported a persist-
ent sensitization of the HPA axis in adulthood even to
mild stressors in women with severe early-life stress. In
response to a psychosocial laboratory stressor, physically
and sexually abused women with and without current
major depression exhibited increased ACTH concentra-
tions compared to controls and non-abused depressed
women. In contrast, only women with early-life stress and
current major depression showed enhanced plasma corti-
sol values 30 to 60 minutes after the stressor.
The results of challenge paradigms using trauma-related
stressors, such as trauma reminders or personalized trau-
matic scripts are also inconclusive. In a symptom provo-
cation study using trauma-related stimuli (combat
sounds) compared to nonspecific arousing stimuli (white
noise), Liberzon et al. [26] observed enhanced plasma
cortisol and catecholamines at baseline, but no differ-
ences in ACTH or cortisol secretion in response to both
stressors (combat sounds, white noise) in patients with
PTSD compared to controls. One major problem with this
study is that plasma samples were drawn immediately
before and after playing a 3 minute audiotape. An effect of
a stressor on cortisol values cannot be expected after such
a short time interval. On the other hand, Elzinga et al. [27]
reported elevated salivary cortisol levels in women with
PTSD during, and shortly after, exposure to a personalized
trauma script. The problem in this study is that the corti-
sol levels were elevated before the script exposure in the
PTSD group compared to the control group, perhaps due
to anticipatory anxiety. It is unclear whether effects would
have been significant if the difference values had been
analyzed or if the baseline differences had been corrected
using cortisol values directly before the stressor as a cov-
ariate.
Finally, in a single case study Otte et al. [31] investigated
subjective distress and salivary cortisol during the first and
20th  session of an imaginal exposure treatment. They
observed extreme anticipatory anxiety before and in the
beginning of the first exposure session, which was mark-
edly reduced at the end of the therapy. However, they
observed no increase in cortisol during first exposure, and
cortisol values at the end of the therapy were not different
from the beginning.
In summary, the results of non-pharmacological chal-
lenge paradigms are as inconclusive as the results of phar-
macological challenge paradigms in PTSD. Studies using
cognitive, psychosocial, or physical stressors revealed no
evidence of abnormalities in cortisol reagibility [28-30].
However, it remains unclear whether findings from cogni-
tive, psychosocial, or physical challenge paradigms can be
generalized to emotional stressors, such as being exposed
to reminders of one's trauma. To our knowledge, only two
studies so far investigated cortisol secretion in PTSD
patients during or after exposure to trauma-related stimuli
with conflicting results: One found no increase in plasma
cortisol in response to the stressor [26], whereas the other
found increased cortisol to personalized traumatic scripts
[27]. However, as detailed above, both studies had limita-
tions that make the interpretation of results difficult.
Thus, it remains unclear whether inquiring about a trau-
matic experience, for example during a psychodiagnostic
interview, for expert opinion, or in the course of exposure-
based therapies, such as narrative exposure therapy [32],
causes a level of stress that activates the HPA axis and
results in excessive cortisol excretion in PTSD patients.
Therefore, the aim of this study was to investigate whether
persons with severe forms of PTSD, such as survivors of
torture and violent oppression, show an excessive stress
response with high cortisol excretion in response to
detailed questioning about their torture/war experiences.
Samples of saliva were taken four times during a diagnos-
tic interview (baseline, pre-stressor, post-stressor, recov-
ery). Individuals with PTSD in the stress group were
interviewed about their torture experiences using a stand-
ardized checklist. Persons with PTSD in the control condi-
tion were interviewed about their absorption behavior in
various situations. Directly before and after the stressor,
all participants performed a memory task, which acted as
a distraction, and rated selected PTSD symptoms on a vis-
ual analog scale.
We hypothesized that participants in the stress group
would show an excessive cortisol excretion after being
questioned about their traumatic (torture/war) experi-
ences. Furthermore, we wanted to investigate differences
in recovery of cortisol levels between the two groups after
the stressor. In addition, we hypothesized that after the
interview persons in the stress group would show worse
performance on the memory task and would rate their
PTSD symptoms and memories as more severe than per-
sons in the control group. Finally, we wanted to explore
the relationship between cortisol levels and severity of
symptom ratings and memories of the most traumatic
event pre- and poststressor.
Methods
Participants
Participants were male refugees suspected by social work-
ers of having PTSD. They were invited to the Psychological
Research Clinic for Refugees of the University of Kon-
stanz, located at the Center for Psychiatry, Reichenau.
Travel expenses and interpreter costs were paid for the par-
ticipants. If resources permitted, they were offered treat-
ment; otherwise they were referred to local therapists. In
the case of ongoing court procedures regarding the state of
asylum, they were offered a brief report on their mentalBMC Psychiatry 2007, 7:54 http://www.biomedcentral.com/1471-244X/7/54
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health status. The procedure was approved by the Ethics
Committee of the University of Konstanz, Germany.
Forty-four male refugees participated in the study. Eleven
participants were excluded from the study: 6 participants
did not fulfill DSM-IV criteria of PTSD, in 2 cases the diag-
nosis of PTSD was doubtful, 1 participant suffered from
an anxiety attack with vomiting at the time of the investi-
gation, 1 participant had undergone thyroid gland opera-
tion and took hormone substituting medication, and 1
refused to give a sample of saliva. The remaining 33 par-
ticipants were assigned at random to the stress condition
(n  = 17) and to the control condition (n  = 16). The
included refugees had the following ethnic backgrounds:
26 Kurds from Turkey, 2 Kosovar Albanians, 2 Afghans, 1
Kosovar Roma, 1 Syrian, and 1 Moroccan. Refugees' mean
age was 34 years (SD = 7.6; age range 22–50 years). There
was no significant age difference between groups, t(31)= -
.82, p = .42 (MControls = 33, SD = 7.9; Mstress group = 35, SD =
7.4). On average participants lived in Germany for 5.3
years (SD = 3.2). Eight persons of the stress group and 8
persons of the control group were smokers.
The sample can be considered as severely traumatized: On
average each participant had experienced 5.4 traumatic
events (SD = 1.6) as measured by the PDS event scale,
including in almost all cases torture (n = 30; 16 in the
experimental group, 14 in the control group). Nine partic-
ipants took antidepressants (stress group: 4, control
group: 5) and 6 neuroleptics (stress group: 3, control
group: 3). Two participants fulfilled criteria of substance
dependence, three abused alcohol as a means of self-med-
ication. Thirty-three participants were suicidal (15 mild, 9
moderate, 9 severe). Sixteen participants were smokers (M
= 13.3 cigarettes/day, SD = 15.8).
Experimental procedure
Diagnostic interviews started at 10 am and lasted on aver-
age about 5 hours. They were conducted with the help of
trained interpreters. For a schematic description of the
procedures see Figure 1.
At the beginning, all procedures were explained to partic-
ipants and written informed consent was obtained. After-
wards, participants gave the first sample of saliva via
Salivette sampling devices (Sarstedt, Nürnbrecht, Ger-
many) and rated their present condition via the valence
and arousal scale of the Self Assessment Manikin [SAM,
[33,34]]. Subsequently, sociodemographic information as
well as medical information was acquired and partici-
pants were interviewed about their current asylum situa-
tion.
In the second part of the interview, participants com-
pleted a computerized nonverbal Delayed-Matching-to-
Sample test (DMS), in which subjects had to memorize
and match complex graphical patterns. The purpose of
this test was to distract participants from the content of
the first part of the diagnostic interview. Subjects were first
presented with a familiarization stimulus for 5 seconds.
Then there was a delay period of 5 seconds during which
subjects were shown a fixation cross in the middle of the
screen. After the delay, two test stimuli were presented
side by side for 5 seconds. One of these stimuli was the
familiarization stimulus, the other one was a new stimu-
lus, similar to the familiarization stimulus, but different
in geometry and color. The subjects' task was to press the
button that corresponded to the location of the familiari-
zation stimulus. The next trial started after a 3 second-
inter-trial delay. In total, 16 trials were conducted, and the
DMS task took about five minutes.
After completing the DMS task, participants rated a sec-
ond time how pleasant/unpleasant and how calm/
aroused they felt at the time and gave a second saliva sam-
ple. Subsequently, using a visual analog scale, they rated
how stressful they perceived the following major symp-
toms of PTSD to have been during the previous 4 weeks:
Experimental design Figure 1
Experimental design. SAM, Self Assessment Manikin; SRS, 
Symptom Rating Scale; DMS, Delayed matching-to-sample 
task. After obtaining informed consent subjects gave the first 
saliva probe and rated their current emotional state via SAM 
(t1). The diagnostic interview continued with gathering of 
sociodemographic information. Before the groups were split 
in a stress and a control group, a memory test (DMS) was 
performed for purpose of distraction. Afterwards a sample of 
saliva was taken, and participants completed the SAM fol-
lowed by the SRS (t2). Subsequently, participants in the stress 
condition were interviewed about their traumatic (torture) 
experiences, whereas participants in the control condition 
were asked about their absorption behavior. Afterwards, 
subjects again completed the DMS for the purpose of distrac-
tion. Then they gave a sample of saliva, and subsequently 
completed the SAM followed by the SRS (t3). After that, 
information about comorbid psychiatric disorders was gath-
ered in a clinical diagnostic interview. At the end of the inter-
view, participants gave the fourth saliva sample and 
completed the SAM (t4).
90 Min 
(SD = 28)
76 Min 
(SD = 32)
68 Min 
(SD = 22)
Experimental design
t1 t1
•C o r t i s o l
• SAM
•C o r t i s o l
• SAM
Sociodemographic
information
Informed
consent
Stress
condition
Control
condition
Clinical diagnostic
interview
t2 t2
•D M S
•C o r t i s o l
• SAM
•S R S
•D M S
•C o r t i s o l
• SAM
•S R S
t3 t3
•D M S
•C o r t i s o l
• SAM
•S R S
•D M S
•C o r t i s o l
• SAM
•S R S
t4 t4
•C o r t i s o l
• SAM
•C o r t i s o l
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nightmares, intrusions, irritability, and disturbed sleep.
Furthermore, they rated how intense their memories of
the worst traumatic experience were at the time and how
stressful and unpleasant the memories of their most trau-
matic event were at that time. Afterwards, subjects had a
15 minute break.
Afterwards, the procedures for the stress and the control
group diverged. In the stress condition, participants were
interviewed about their experiences during torture using
the Vivo Checklist of War, Detention, and Torture events
(Note: The German and English version of this question-
naire can be downloaded from the vivo foundation web
page [35], see vivo publications). In the non-stress condi-
tion participants were interviewed about absorption
behavior (e.g., "When something absorbs my mind, I
have to make an effort to notice what happens around
me"). This phase of the interview took on average 78 min-
utes (SD = 27 minutes). The remainder of the experiment
was again identical for stress and control groups.
Participants completed the DMS test a second time for dis-
traction, gave a third saliva sample and completed the
SAM rating scale again. Afterwards, they once again rated
the intensity of the major symptoms of PTSD during the
last 4 weeks, how much they were ruminating about their
traumatic experience at that time, and how stressful and
unpleasant those memories were at the time. In addition,
they were asked whether the memories of their most trau-
matic experience were more intense, less intense, or
unchanged.
In the third phase of the interview, participants were asked
about symptoms of posttraumatic stress disorder with the
Posttraumatic Diagnostic Scale [PDS, [36]], symptoms of
depression and anxiety via the Hopkins Symptom Check-
list-25 [HSCL-25, [37]], and current suicidality using part
C of the German version [38] of the Mini International
Neuropsychiatric Interview [M.I.N.I., [39,40]]. Further-
more, participants were asked about quality and duration
of sleep during the last night and during the last 4 weeks
with a modified version of the Pittsburg Sleep Quality
Index [PSQI, [41]]. For mean questionnaire values and
standard errors see Table 1. Approximately one hour into
this third phase, subjects once again rated via the SAM
their current affective state and arousal and gave a fourth
saliva sample. After giving this saliva sample, subjects
were able to take as much time as they wanted for a break,
following which the remaining questionnaires of this
phase were completed.
Analysis of saliva samples
Directly after the diagnostic interview, saliva samples were
refrigerated at -18°C. They were sent to an external labo-
ratory for analysis (Prof. Dr. C. Kirschbaum, TU Dresden,
Germany), where free cortisol levels in saliva were meas-
ured using a commercially available chemiluminescence
assay (IBL, Hamburg, Germany). Nine saliva devices did
not contain enough saliva for analysis and were coded as
"missing" in the analysis (2 at t1, 1 at t2, 3 at t3, 3 at t4).
Factors that may influence cortisol levels such as age, med-
ications, alcohol and nicotine consumption, aspects of
sleeping behavior and comorbid psychiatric disorders
(depression, substance abuse) were recorded. Subjects
were not allowed to drink coffee or tea or to smoke during
the diagnostic interview.
Statistical analysis
Baseline valence and arousal ratings (at times t1 and t2)
were analyzed by analyses of variance (ANOVAs) with
repeated measures factor Time (t1, t2) and between factor
Group (stress group, control group). Valence and arousal
ratings after the stress intervention in the experimental
group were analyzed by ANCOVAs with repeated meas-
ures factor Time (t3, t4), between factor Group, and
valence and arousal ratings at t2 as covariates, respectively.
Visual analog symptom rating scale data as well as reac-
tion times and performance in the DMS task were ana-
lyzed by an ANOVA with repeated measures factor Time
(t2, t3) and between factor Group (stress group, control
group).
Cortisol data were analyzed using an ANOVA with Group
as fixed effect and Time as repeated measure (t1, t2, t3, t4).
Participants' HSCL-D, PDS-Intrusion, PDS-Avoidance,
and PDS-Hyperarousal scores were included as covariates
but were excluded if they showed no significant influence.
Baseline Cortisol (t1, t2) was investigated using repeated
measures factor Time, cortisol reagibility to the stress
intervention (t2, t3) was investigated by subtracting corti-
Table 1: Questionnaire values
Total 
average
Stress group Control 
group
Questionnaire MS EMS EMS E One-way 
ANOVA
PDS-Intrusion 10.36 .51 10.12 .68 10.63 .79 n.s.
PDS-Avoidance 12.94 .49 12.88 .71 13.00 .71 n.s.
PDS-Hyperarousal 10.36 .49 9.88 .72 10.88 .65 n.s.
PDS Total 33.67 1.17 32.88 1.53 34.5 1.81 n.s.
HSCL-Anxiety 2.71 .09 2.74 .12 2.68 .14 n.s.
HSCL-Depression 2.80 .09 2.71 .09 2.89 .15 n.s.
h sleep last night 3.18 .31 3.04 .43 3.33 .44 n.s.
Average h sleep 
last 4 weeks
4.59 .26 4.39 .36 4.78 .37 n.s.
Mean questionnaire values (M) and standard errors (SE) for each group. 
PDS, Posttraumatic Diagnostic Scale; HSCL, Hopkins Symptom 
Checklist.BMC Psychiatry 2007, 7:54 http://www.biomedcentral.com/1471-244X/7/54
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sol levels at t2 from levels at t3 and analyzing the difference
as the dependent variable, and the post-stressor dynamics
(t3, t4) were investigated by subtracting cortisol levels at t3
from levels at t4  and analyzing the difference as the
dependent variable [42]. One subject was excluded from
the analysis of cortisol data at t3 and t4 because he became
highly aggressive during the interview and appeared as an
extreme outlier in cortisol levels.
Data were analyzed using SPSS 13.0. All analyses used
mixed model AN(C)OVA, which is particularly suited for
analysis of data with missing values [43]. Subject was
nested in Group and included as a random effect in all
analyses.
Results
Analysis of cortisol data
The ANOVA revealed a main effect of Time, F(3,75.38) =
4.31, p = .007, showing that cortisol values decreased in
both groups over time with no significant difference
between groups, interaction Time × Group, F(3,75.38) =
.63, p = .60 (compare Figure 2).
The analysis of baseline cortisol (t1 and t2) revealed no sig-
nificant differences between groups, F(1,31.02) = .002.
However, there was a trend for a main effect of Time,
F(1,29.46) = 3.88, p = .06, indicating lower cortisol values
at t2 compared to t1. Covariates revealed no significant
influence and were therefore not included in the ANOVA.
The analysis of cortisol reagibility in response to the stres-
sor (cortisol level at t2 subtracted from cortisol level at t3)
revealed also no effect of Group, F(1,27) = 1.79, p = .19.
Again, covariates revealed no significant influence and
were therefore not included in the ANOVA. The correla-
tions of differences in cortisol (t3-t2) with differences in
scores (t3-t2) in visual analog symptom rating scales also
revealed no significant effects.
Furthermore, the analysis of cortisol dynamics after the
stressor (cortisol level at t3 subtracted from cortisol level at
t4) revealed no main effect of Group, F(1,26) = .27, p =
.61, or significant influence of covariates.
Analysis of valence and arousal data
Repeated measures ANOVA for valence ratings at t1 and t2
revealed no main effect of Group, F(1,31) = .02, p = .89,
as well as no interaction of Group × Time, F(1,31) = .11,
p = .75. However, there was a main effect of Time, F(1,31)
= 4.64, p = .04, indicating that valence ratings were more
positive at t2 than t1 (compare Table 2). Repeated meas-
ures ANOVA for arousal ratings at t1 and t2 revealed no
main effects of Group, F(1,31) = .34, p = .57, or Time,
F(1,31) = .35, p = .56, or interaction of Group × Time,
F(1,31) = .06, p = .80.
For valence ratings at t3 and t4, no main effect of Time,
F(1,31) = .99, p  = .33, no difference between groups,
F(1,30) = .75, p = .39, or interaction of Time × Group,
F(1,31) = .13, p = .72, was observed. The covariate (rating
at t2) was significant, F(1,30) = 4.27, p = .05, indicating
that high ratings at t2 also led to higher ratings at t3 and t4.
Similarly, for arousal ratings no difference between
groups, F(1,30) = .27, p = .61, no main effect of Time,
F(1,31) = .05, p = .82, or interaction of Time × Group,
F(1,31) = .32, p = .58, was observed, while the covariate
(rating at t2) was again significant, F(1,30) = 16.05, p <
.0001, indicating that high ratings at t2 also led to higher
ratings at t3 and t4.
Analysis of visual analog symptom rating scales
Repeated measurement ANOVAs revealed no significant
interaction of Time × Group at t2 and t3 for the ratings of
the following symptoms: nightmares, F(1,31) = 2.85, p =
.10, intrusions, F(1,31) = .01, p = .91, irritability, F(1,31)
= .62, p = .44, sleep disturbances, F(1,31) = .01, p = .93,
and thinking of one's worst event at this very moment,
F(1,31) = .01, p = .91. In contrast, a significant interaction
of Time × Group, F(1,31) = 4.44, p = .04, revealed that the
control group exhibited a tendency to rate memories of
their worst event as less unpleasant and stressful at t3 com-
pared to t2, F(1,15) = 3.64, p = .08, whereas the stressed
experimental group showed no such tendency, F(1,16) =
1.04, p = .32.
With respect to the question of whether memories of the
most traumatic event were more intense than before, less
intense, or unchanged, no significant differences between
Cortisol results Figure 2
Cortisol results. Time course of mean cortisol levels (LSM 
and SE) for each group.BMC Psychiatry 2007, 7:54 http://www.biomedcentral.com/1471-244X/7/54
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the stress and the control group were observed, χ2(df = 2)
= 1.13, p = .57.
Analysis of the delayed match-to-sample task
Participants performed extremely poorly in the delayed
match-to-sample task: they made mistakes in 30.7% of tri-
als at t2 and in 36.1% of trials at t3. (Note: in a healthy
population (9 male, 7 female; mean age 30 years) error
rates of 1.5% were observed). No significant effects or
interactions on performance were found; notably, partici-
pants in the stress group did not perform worse on the sec-
ond run than the control group, interaction of Time ×
Group, F(1,28.7) = .16, p = .70.
The analysis of response latencies showed that partici-
pants responded overall faster in the second run of the
DMS task compared to the first run, F(1,26.3) = 10.66, p
= .003. However, no main effect of Group, F(1,27.3) =
1.42, p = .24, or interaction of Time × Group, F(1,26.3) =
.07, p = .80, was observed.
Discussion
This study found no difference in cortisol excretion in par-
ticipants in the supposed stress condition as compared to
individuals in the control group, although both groups
did show the typical diurnal decline in cortisol. Corre-
spondingly, ratings of subjective well-being and PTSD
symptoms did not show any significant difference
between both groups. The results suggest that a compre-
hensive diagnostic interview, including questions about
traumatic events, is not a stressor that triggers an HPA-axis
based alarm response, even for severely traumatized per-
sons such as survivors of torture.
Cortisol response to a trauma-related stressor
Previous studies commonly used a general stressor (psy-
chosocial, cognitive etc.) and compared cortisol reagibil-
ity of traumatized persons with (and without) PTSD to
that of a control group being exposed to the same stressor
[26,28-30]. In contrast, the present study compared the
effect of a stressful versus a non-stressful interview in
PTSD patients.
To our knowledge, the only study with a somewhat simi-
lar design was conducted by Elzinga et al. [27]. They com-
pared the cortisol responses to personalized trauma
scripts of persons with current PTSD to those of persons
with life-time PTSD and found increased cortisol secretion
during script exposure in the current PTSD compared to
the life-time PTSD group. Whereas in the present study
subjects were interviewed about their traumatic events
with a standardized questionnaire on torture/war experi-
ences, persons in the Elzinga et al. study were read two
trauma scripts of approximately 1 minute length describ-
ing a severe childhood sexual or physical abuse event
(script 1) and a situation in which the person felt alone
and abandoned (script 2). Perhaps listening to one's own
traumatic experience read aloud in present-tense is a more
severe stressor than answering questions about whether
one has encountered certain experiences, and thus leads
to increased cortisol secretion. However, it must be noted
that Elzinga et al. compared the reaction to trauma scripts
between patients with lifetime versus patients with cur-
rent PTSD, while the present study compares the effects of
trauma-related questioning with a trauma-irrelevant ques-
tionnaire in current PTSD patients; thus the similarity
between the Elzinga et al. and the current study is limited.
Finally, the case study of Otte et al. [31] is most directly
comparable to the present experimental procedure in that
a PTSD patient underwent imaginal exposure therapy,
while subjective distress as well as cortisol was measured
before, during and after exposure in the first and 20th
treatment session. In contrast to our results, subjective dis-
tress before and in the first 15 to 30 minutes of the first
treatment session was very high, while afterwards subjec-
tive distress levels declined. In the present study, partici-
pants were already considerably distressed when we
started the interview, which may have induced a ceiling
effect. However, in agreement with our findings, Otte et
al. also observed no accompanying cortisol response in
response to imaginal trauma exposure, and cortisol
dynamics were essentially the same during the first and
the 20th session.
Possible influences on HPA activity following a stressor
Nature of the stressor
A meta-analysis evaluating the influence of chronic stress
on the HPA axis found that chronic stress which threatens
physical integrity (e.g. combat, traumatic stress) leads to a
diurnal profile of cortisol excretion that is high and flat,
whereas stress posing a threat to the social self (e.g.
divorce), was associated with higher cortisol at specific
times in the day, including morning and afternoon/
evening [44]. Furthermore, in a meta-analysis evaluating
the influence of acute stressors on cortisol responses in
healthy controls, significant cortisol responses were
induced by cognitive tasks (d = .2), public speaking/verbal
interaction tasks (d = .39), and public speaking/cognitive
task combinations (d = .87). However, the influence of
emotion induction or noise exposure were not significant
[10].
We currently do not know of a study that compared the
influence of various stressors (e.g., psychosocial, cogni-
tive, physical, trauma reminder) in the same patient
group. Perhaps some of the inconsistent literature could
be attributed to the fact that cortisol responses in trauma-
tized persons vary with the type of stressor applied. ABMC Psychiatry 2007, 7:54 http://www.biomedcentral.com/1471-244X/7/54
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threat to the social self, for instance, would be a likely can-
didate.
Core emotions elicited by the stressor
It has been hypothesized that the direction and magni-
tude of the HPA response to a stressor is influenced by the
emotion(s) elicited by the situation [44]. Consistent with
this notion, a recent meta-analysis found that situations
likely to elicit shame (e.g. sexual abuse) were associated
with significantly higher afternoon/evening cortisol,
whereas those evoking loss (e.g. death of spouse) were
accompanied by a flattened diurnal profile with lower
morning cortisol but higher afternoon/evening cortisol
[44]. It is possible that the main emotion(s) elicited
through a trauma reminder (e.g., helplessness, fear, sad-
ness, anger/aggression) might also influence the pattern
of cortisol excretion. Support for this notion comes from
the observation that one patient in the present study
became severely aggressive during the diagnostic inter-
view and correspondingly exhibited significantly
increased cortisol levels that showed up as extreme out-
liers and thus had to be excluded from the analysis. To our
knowledge, no study so far investigated predominant
emotions in PTSD and cortisol profiles and reagibility.
Controllability of the stressor
Another influencing factor may be controllability of the
stressor. In a meta-analysis, chronic stress that was rated as
potentially controllable was associated with significantly
higher morning cortisol whereas uncontrollable stress was
associated with lower morning cortisol [44]. Similarly,
another meta-analysis evaluating the effect of acute stres-
sors on cortisol responses in healthy controls showed that
uncontrollable situations led to greater cortisol changes
than those that were controllable [10]. Currently, to our
knowledge, no study exists that investigated cortisol
responses in relation to trauma reminders that also evalu-
ated whether the participating persons experienced the sit-
uation as controllable or uncontrollable.
Timing of traumatic stressor (early life vs. adulthood)
Exposure to chronic or traumatic stress early in life, when
the nervous system is still developing, may result in dis-
tinct alterations of the HPA axis compared to when the
stressor occurs later in life. Support for this notion comes
from a study by Heim et al. [30] who found a persistent
sensitization of the HPA axis and autonomic stress
response in women with severe early life stress. However,
Santa Ana et al. [28] did not find differences between
child or adult trauma with respect to ACTH secretion –
both groups showed a flattened ACTH response.
Conclusion
A comprehensive diagnostic interview, including exten-
sive questioning of traumatic events does not seem to
cause an HPA-axis based alarm response or changes in
psychological measures, even for severely traumatized
persons such as survivors of torture. Nevertheless, the
present results should not be taken to mean that question-
ing about traumatic experiences is not taxing for both
patients with PTSD and interviewers. On the contrary,
interviews should continue to be conducted within a
secure, supportive and empathic environment in which
the interviewee has as much control over the situation as
possible. In conclusion, assuming that basic therapeutic
variables are met, we do not have any psychophysiologi-
cal evidence that a careful trauma diagnosis floods a
trauma survivor with stress hormones or causes them
additional distress.
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Table 2: Valence and arousal ratings
Stress group Control group
Time LSM SE LSM SE
Valence
t1 6.82 .48 6.81 .50
t2 6.06 .48 6.25 .50
t3 5.97 .55 6.72 .57
t4 5.74 .55 6.22 .57
Arousal
t1 5.29 .59 5.81 .61
t2 5.12 .59 5.38 .61
t3 5.60 .52 5.06 .53
t4 5.30 .52 5.18 .53
Least square means (LSM) and standard errors (SE) of valence and 
arousal ratings for each group. The SAM scale ranged from 1 to 9 with 
1 = "highly pleasant/low arousing" and 9 = "highly unpleasant/highly 
arousing".BMC Psychiatry 2007, 7:54 http://www.biomedcentral.com/1471-244X/7/54
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